Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Saved in:
| Title: | Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial. |
|---|---|
| Authors: | Tromp J; Saw Swee Hock School of Public Health, National University of Singapore & the National University Health System, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Kosiborod MN; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.; George Institute for Global Health, Sydney, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia., Angermann CE; Comprehensive Heart Failure Centre and Department of Medicine I (Cardiology), University and University Hospital of Würzburg, Würzburg, Germany., Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center and Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA., Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA., Ponikowski P; Institute of Heart Diseases, Medical University, Wroclaw, Poland., Biegus J; Institute of Heart Diseases, Medical University, Wroclaw, Poland., Ferreira JP; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal., Nassif ME; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA., Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA., Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany.; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Blatchford JP; Elderbrook Solutions GmbH on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Steubl D; Boehringer Ingelheim International, Ingelheim, Germany.; Department of Nephrology, Klinikum rechts der Isar, Faculty of Medicine, Technical University, Munich, Germany., Voors AA; University of Groningen Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. |
| Source: | European journal of heart failure [Eur J Heart Fail] 2024 Apr; Vol. 26 (4), pp. 963-970. Date of Electronic Publication: 2024 Apr 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1879-0844 |
|---|---|
| DOI: | 10.1002/ejhf.3218 |
